The IPO provides a cash runway but at massive dilution (~50.8% share increase) and a going-concern overhang. Monitor Nasdaq listing approval and subsequent trading volume; the warrants (DUKRW) may offer leveraged exposure if the stock stabilizes above $8.60. The company's limited revenue base and accumulated deficit suggest high risk of further capital needs.
Executive Summary
DUKE Robotics Corp. completed a firm-commitment underwritten IPO of 1,125,000 units at $8.20 per unit, each consisting of one share of common stock and one warrant (exercise price $8.60), raising gross proceeds of $9,225,000. Net proceeds of ~$7,977,000 will fund R&D, sales expansion, marketing, business development, and working capital. The offering is contingent on Nasdaq listing approval; the company has a going-concern warning, limited revenue ($377K in 2025), and an accumulated deficit of $12.4M. Immediate dilution of $5.81 per share to new investors is substantial.
Key Financial Metrics
Key Facts
- 1,125,000 units priced at $8.20/unit, each consisting of 1 share + 1 warrant (exercise price $8.60, 5-year term)
- Gross proceeds of $9,225,000; net proceeds ~$7,977,000 after underwriting discount of $738,000 (8.0%) and estimated expenses
- Shares outstanding increase from 2,260,383 to 3,407,977 (50.8% dilution to existing holders)
- Immediate dilution of $5.81 per share to new investors (as adjusted net tangible book value of $2.39 vs. offering price of $8.20)
- Company has going-concern warning, accumulated deficit of $12.4M, and only $377K revenue in 2025 (up from $108K in 2024)
- 180-day lock-up for officers, directors, and certain principal shareholders
- Over-allotment option for up to 168,750 additional shares/warrants (45-day option)
- Sole book-running manager: Maxim Group LLC; Representative's warrants for 103,500 shares at $10.25
Financial Impact
Gross proceeds of $9,225,000; net proceeds ~$7,977,000; immediate dilution of $5.81 per share (71% of offering price)
Risk Factors
- Nasdaq listing approval is a condition to closing; failure would terminate the offering
- Going-concern uncertainty persists despite the capital raise; accumulated deficit of $12.4M
- Immediate 71% dilution from offering price to book value; further dilution from warrants and options
- Limited revenue ($377K in 2025) and heavy reliance on government contracts and geopolitical stability in Israel
- Selling stockholders (170,954 shares) purchased at ~$1.70/share, creating overhang at higher prices
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B4 Filing (Primary) | 0001213900-26-058179 |
| Document: 0001213900-26-058179-index-headers.html | 0001213900-26-058179 |
| Document: 0001213900-26-058179-index.html | 0001213900-26-058179 |
| Document: 0001213900-26-058179.txt | 0001213900-26-058179 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 8-K | $4.21 | awaiting T+20 | — | $4.19 (−0.36%) |
Oct 22, 2026 5d ago | DEFA14A | $4.15 | awaiting T+20 | — | $4.19 (+0.96%) |
Oct 22, 2026 5d ago | DEF 14A | $4.15 | awaiting T+20 | — | $4.19 (+0.96%) |
Oct 6, 2026 21d ago | 3 | $5.17 | awaiting T+20 | — | $4.19 (−18.96%) |
Oct 6, 2026 21d ago | 3 | $5.17 | awaiting T+20 | — | $4.19 (−18.96%) |
Oct 2, 2026 25d ago | Press Release | $5.32 | awaiting T+20 | — | $4.19 (−21.24%) |
Sep 17, 2026 5w ago | 8-K | $5.35 $4.29 | ▼ −19.81% | ▼ −21.02% | $4.19 (−21.68%) |
Aug 24, 2026 9w ago | EFFECT | $5.67 $5.47 | ▲ +3.53% | ▲ +3.54% | $4.19 (+26.10%) |
Aug 18, 2026 10w ago | S-3 | $5.41 $5.26 | ▲ +2.77% | ▲ +1.03% | $4.19 (+22.55%) |
Aug 13, 2026 10w ago | 8-K | $5.60 $5.39 | ▼ −3.75% | ▼ −2.00% | $4.19 (−25.18%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers